A comparison of changes in proteasomal subunit expression in the substantia nigra in Parkinson's disease, multiple system atrophy and progressive supranuclear palsy

Brain Research

Volumn 1326, Issue , 2010, Pages 174-183

  Bukhatwa, Salma ^a   Zeng, Bai Yun ^a   Rose, Sarah ^a   Jenner, Peter ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Neurodegenerative disease; Proteasome complex

Indexed keywords

GLIAL FIBRILLARY ACIDIC PROTEIN; PROTEASOME; PROTEASOME 20S ALPHA4; PROTEASOME 20S ALPHA6; PROTEASOME 20S BETA3; PROTEASOME 20S BETA5I; TYROSINE 3 MONOOXYGENASE; UBIQUITIN; UNCLASSIFIED DRUG;

ARTICLE; ASTROCYTE; BRAIN TISSUE; COMPARATIVE STUDY; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; ENZYME LOCALIZATION; ENZYME STRUCTURE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; PARKINSON DISEASE; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; PROTEIN EXPRESSION; SHY DRAGER SYNDROME; SUBSTANTIA NIGRA;

AGED; AGED, 80 AND OVER; FEMALE; GENE EXPRESSION REGULATION; GLIAL FIBRILLARY ACIDIC PROTEIN; HUMANS; MALE; MIDDLE AGED; MULTIPLE SYSTEM ATROPHY; NEURONS; PARKINSON DISEASE; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN SUBUNITS; SUBSTANTIA NIGRA; SUPRANUCLEAR PALSY, PROGRESSIVE; TYROSINE 3-MONOOXYGENASE;

EID: 77950051363     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2010.02.045     Document Type: Article

References (45)

1. Adori C., Low P., Moszkovkin G., Bagdy G., László L., and Kovács G.G. Subcellular distribution of components of the ubiquitin-proteasome system in non-diseased human and rat brain. J. Histochem. Cytochem. 54 (2006) 263-267
2. Barrachina M., Castaño E., Dalfó E., Maes T., Buesa C., and Ferrer I. Reduced ubiquitin C-terminal hydrolase-1 expression levels in dementia with Lewy bodies. Neurobiology 22 (2006) 265-273
3. Bulteau A.L., Lundberg K.C., Humphries K.M., Sadek H.A., Szweda P.A., Friguet B., and Szweda L.I. Oxidative modification and inactivation of the proteasome during coronary occlusion/reperfusion. J. Biol. Chem. 276 (2001) 30057-30063
4. Carrard G., Bulteau A.L., Petropoulos I., and Friguet B. Impairment of proteasome structure and function in aging. Int. J. Biochem. Cell Biol. 34 (2002) 1461-1474
5. DeMartino G.N., and Slaughter C.A. The proteasome, a novel protease regulated by multiple mechanisms. J. Biol. Chem. 274 (1999) 22123-22126
6. Dickson D.W., Rademakers R., and Hutton M.L. Progressive supranuclear palsy: pathology and genetics. Brain Pathol. 17 (2007) 74-82
7. El-Khodor B.F., Kholodilov N.G., Yarygina O., and Burke R.E. The expression of mRNAs for the proteasome complex is developmentally regulated in the rat mesencephalon. Dev. Brain Res. 129 (2001) 47-56
8. Emori Y., Tsukahara T., Kawasaki H., Ishiura S., Sugita H., and Suzuki K. Molecular cloning and functional analysis of three subunits of yeast proteasome. Mol. Cell. Biol. 11 (1991) 344-353
9. Fillon G., and Kahle P.J. Alpha-synuclein transgenic mice: relevance to multiple system atrophy. Mov. Disord. 20 Suppl 12 (2005) S64-S66
10. Furukawa Y., Vigouroux S., Wong H., Guttman M., Rajput A.H., Ang L., Briand M., Kish S.J., and Briand Y. Brain proteasomal function in sporadic Parkinson's disease and related disorders. Ann. Neurol. 51 (2002) 779-782
11. Gai W.P., Pountney D.L., Power J.H., Li Q.X., Culvenor J.G., McLean C.A., Jensen P.H., and Blumberg P.C. Alpha-synuclein fibrils constitute the central core of oligodendroglial inclusion filaments in multiple system atrophy. Exp. Neurol. 181 (2003) 68-78
12. Giasson B.I., Duda J.E., Murray I.V., Chen Q., Souza J.M., Hurtig H.I., Ischiropoulos H., Trojanowski J.Q., and Lee V.M. Oxidative damage linked to neurodegeneration by selective alpha-synuclein nitration in synucleinopathy lesions. Science 290 (2000) 985-989
13. Glickman M.H., and Ciechanover A. The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction. Physiol. Rev. 82 (2002) 373-428
14. Goedert M. The significance of tau and a-synuclein inclusions in neurodegenerative diseases. Curr. Opin. Genet. Dev. 11 (2001) 342-351
15. Grunblatt E., Mandel S., Jacob-Hirsch J., Zeligson S., Amariglo N., Rechavi G., Li J., Ravid R., Roggendorf W., Riederer P., and Youdim M.B. Gene expression profiling of parkinsonian substantia nigra pars compacta; alterations in ubiquitin-proteasome, heat shock protein, iron and oxidative stress regulated proteins, cell adhesion/cellular matrix and vesicle trafficking genes. J. Neural. Transm. 111 (2004) 1543-1573
16. Grune T., Reinheckel T., and Davies K.J. Degradation of oxidized proteins in K562 human hematopoietic cells by proteasome. J. Biol. Chem. 271 (1996) 15504-15509
17. Gu M., Owen A.D., Toffa S.E., Cooper J.M., Dexter D.T., Jenner P., Marsden C.D., and Schapira A.H. Mitochondrial function, GSH and iron in neurodegeneration and Lewy body diseases. J. Neurol. Sci. 158 (1998) 24-29
18. Hauw J.J., Daniel S.E., Dickson D., Horoupian D.S., Jellinger K., Lantos P.L., McKee A., Tabaton M., and Litvan I. Preliminary NINDS neuropathologic criteria for Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy). Neurology 44 (1994) 2015-2019
19. Hoffman L., and Rechsteiner M. Regulatory features of multicatalytic and 26S proteases. Curr. Top. Cell. Regul. 34 (1996) 1-32
20. Hope A.D., Lashley T., Lees A.J., and de Silva R. Failure in heat-shock protein expression in response to UBB+1 protein in progressive supranuclear palsy in humans. Neurosci. Lett. 359 (2004) 94-98
21. Jellinger K.A. Neuropathological spectrum of synucleinopathies. Mov. Disord. 18 Suppl 6 (2003) S2-S12
22. Komori T. Tau-positive glial inclusions in progressive supranuclear palsy, corticobasal degeneration and Pick's disease. Brain Pathol. 9 (1999) 663-679
23. Lam Y.A., Lawson T.G., Velayutham M., Zweier J.L., and Pickart C.M. A proteasomal ATPase subunit recognizes the polyubiquitin degradation signal. Nature 416 (2002) 763-767
24. Langerveld A.J., Mihalko D., DeLong C., Walburn J., and Ide C.F. Gene expression changes in postmortem tissue from the rostral pons of multiple system atrophy patients. Mov. Disord. 22 (2007) 766-777
25. MacInnes N., Iravani M.M., Perry E., Piggott M., Perry R., Jenner P., and Ballard C. Proteasomal abnormalities in cortical Lewy body disease and the impact of proteasomal inhibition within cortical and cholinergic systems. J. Neural. Transm. 115 (2008) 869-878
26. Marx F.P., Soehn A.S., Berg D., Melle C., Schiesling C., Lang M., Kautzmann S., Strauss K.M., Franck T., Engelender S., Pahnke J., Dawson S., von Eggeling F., Schulz J.B., Riess O., and Krüger R. The proteasomal subunit S6 ATPase is a novel synphilin-1 interacting protein-implications for Parkinson's disease. FASEB J. 21 (2007) 1759-1767
27. Matiuhin Y., Kirkpatrick D.S., Ziv I., Kim W., Dakshinamurthy A., Kleifeld O., Gygi S.P., Reis N., and Glickman M.H. Extraproteasomal Rpn10 restricts access of the polyubiquitin-binding protein Dsk2 to proteasome. Mol. Cell 32 (2008) 415-425
28. McNaught K.S., and Jenner P. Proteasomal function is impaired in substantia nigra in Parkinson's disease. Neurosci. Lett. 297 (2001) 191-194
29. McNaught K.S., Belizaire R., Jenner P., Olanow C.W., and Isacson O. Selective loss of 20S proteasome alpha-subunits in the substantia nigra pars compacta in Parkinson's disease. Neurosci. Lett. 326 (2002) 155-158
30. McNaught K.S., Belizaire R., Isacson O., Jenner P., and Olanow C.W. Altered proteasomal function in sporadic Parkinson's disease. Exp. Neurol. 179 (2003) 38-46
31. Noda C., Tanahashi N., Shimbara N., Hendil K.B., and Tanaka K. Tissue distribution of constitutive proteasomes, immunoproteasomes, and PA28 in rats. Biochem. Biophys. Res. Commun. 277 (2000) 348-354
32. Ozawa T., Paviour D., Quinn N.P., Josephs K.A., Sangha H., Kilford L., Healy D.G., Wood N.W., Lees A.J., Holton J.L., and Revesz T. The spectrum of pathological involvement of the striatonigral and olivopontocerebellar systems in multiple system atrophy: clinicopathological correlations. Brain 127 (2007) 2657-2671
33. Papp M.I., Kahn J.E., and Lantos P.L. Glial cytoplasmic inclusions in the CNS of patients with multiple system atrophy (striatonigral degeneration, olivopontocerebellar atrophy and Shy-Drager syndrome). J. Neurol. Sci. 94 (1989) 79-100
34. Pollanen M.S., Dickson D.W., and Bergeron C. Pathology and biology of the Lewy body. J. Neuropathol. Exp. Neurol. 52 (1993) 183-191
35. Pountney D.L., Chegini F., Shen X., Blumbergs P.C., and Gai W.P. SUMO-1 marks subdomains within glial cytoplasmic inclusions of multiple system atrophy. Neurosci. Lett. 381 (2005) 74-79
36. Rechsteiner M., Realini C., and Ustrell V. The proteasome activator 11S REG (PA28) and class I antigen presentation. Biochem. J. 345 (2000) 1-15
37. Richter-Landsberg C., and Bauer N.G. Tau-inclusion body formation in oligodendroglia: the role of stress proteins and proteasome inhibition. Int. J. Dev. Neurosci. 22 (2004) 443-451
38. Shoffner J., Watts R., Juncos J., Torroni A., and Wallace D. Mitochondrial oxidative phosphorylation defects in Parkinson's disease. Ann. Neurol. 30 (1991) 332-339
39. Snyder, H., Mensah, K., Theisler, C., Lee, J., Matouschek, A., Wolozin, B., 2003. Aggregated and monomeric alpha-synuclein bind to the S6' proteasomal protein and inhibit proteasomal function. J. Biol. Chem. 278, 11753-11759.
40. Soza A., Knuehl C., Groettrup M., Henklein P., Tanaka K., and Kloetzel P.M. Expression and subcellular localization of mouse 20S proteasome activator complex. PA28. FEBS Lett. 413 (1997) 27-34
41. Spillantini M.G., Crowther R.A., Jakes R., Hasegawa M., and Goedert M. alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with Lewy bodies. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 6469-6473
42. Tofaris G.K., Razzaq A., Ghetti B., Lilley K.S., and Spillantini M.G. Ubiquitination of alpha-synuclein in Lewy bodies is a pathological event not associated with impairment of proteasome function. J. Biol. Chem. 278 (2003) 44405-44411
43. Voges D., Zwickl P., and Baumeister W. The 26S proteasome: a molecular machine designed for controlled proteolysis. Ann. Rev. Biochem. 68 (1999) 1015-1068
44. Zeng B.-Y., Iravani M.M., Lin S.T., Irifune M., Kuoppamäki M., Al-Barghouthy G., Smith L., Jackson M.J., Rose S., Medhurst A.D., and Jenner P. MPTP treatment of common marmosets impairs proteasomal enzyme activity and decreases expression of structural and regulatory elements of the 26S proteasome. Eur. J. NeuroSci. 23 (2006) 1766-1774
45. Zouambia M., Fischer D.F., Hobo B., De Vos R.A., Hol E.M., Varndell I.M., Sheppard P.W., and Van Leeuwen F.W. Proteasome subunit proteins and neuropathology in tauopathies and synucleinopathies: consequences for proteomic analyses. Proteomics 8 (2008) 1221-1236